FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) this morning announced that FinCanna will share 50 percent of the profits from Cultivation Technologies’ interim medical cannabis extraction facility operating in Coachella, California.
Marijuana Investing
Global Payout, Inc. (GOHE) Subsidiary Teams with Pegasus Fintech, Inc. to Develop Cryptocurrency-Based Token
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has established a strategic partnership with Pegasus Fintech, Inc.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Highlights Positive Pre-Clinical Data Related to Biosynthesis Platform
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced results from a study co-sponsored by InMed and the University of British Columbia.
PotNetwork Holding, Inc. (POTN) Subsidiary Enhances Product Line
PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a selection of premium honey products.
Grey Cloak Tech, Inc. (GRCK) Acquires Eqova Life Sciences
Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction.
EVIO, Inc. (EVIO) Opens Fifth Testing Location in Eastern Oregon
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced the opening of its fifth testing location in eastern Oregon.
Tokyo Smoke closes on upsized $6 million Series B round
Funding was oversubscribed by 20%, led by Aphria and Green Acre Capital.
InMed: A Text Book Lesson in how Biotechs Drive Share Value Through Innovation.
InMed announces results of a study co-sponsored with the University of British Columbia. The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, resulting in enhanced drug uptake via the cornea and lens. This study further validates the Company’s capacity to conduct a wide spectrum of drug development activities
SinglePoint, Inc. (SING) and AppSwarm, Inc. (SWRM) Enter LOI to Conduct Joint Roll-Out of Cannabis Mobile Apps
Specialized holding company SinglePoint, Inc. (OTC: SING) and technology development company AppSwarm, Inc. (OTC: SWRM) this morning announced their entry into a Letter of Intent related to a joint roll-out of mobile applications specifically geared to the cannabis industry.
Global Payout, Inc. (GOHE) Enters Final Stages of Audit in Preparation for Uplisting to OTCQB Venture Marketplace
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is in the final stages of performing a two-year audit in an effort to become a fully reporting SEC company.
MYM Announces Closing of First Tranche of Non-Brokered Financing
MYM Nutraceuticals Inc., (CSE: MYM) announces it has closed the first tranche of its non-brokered private placement of 5,709,000 units at a price of $0.50 per unit for gross proceeds of $2,854,500.
Global Payout, Inc. is Finalizing Audit in Preparation for its Listing on the OTCQB Venture Marketplace.
Global Payout, Inc. (OTCPink: GOHE) announces it is in the final stages of performing a 2-year audit to become a fully reporting SEC company. Upon completion of the audit, GOHE will immediately apply to be listed on the OTCQB Venture Marketplace..
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) to Hold Web-Meeting on November 1
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Holding a Web-Meeting
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Presenting at Cannabis-Based Science & Medicine Conference
InMed Pharmaceuticals this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference.
Innovation Drives Value for Leading Cannabis Biotechs
As an increasing volume of scientific research leans toward the efficacy of cannabis-based drugs, innovative biotech companies are advancing their R&D to develop therapeutic candidates that envelop the potential health benefits of the marijuana plant.